Welcome to American Journal of Biomedical Sciences
 
  Home    Missions and Scope    Editorial Board    Instructions for Authors    Contact Us

 

 

Am. J. Biomed. Sci. 2012, 4(2), 123-131; doi: 10.5099/aj120200123
Received: 15 November 2011; | Revised: 13 December 2011; | Accepted: 22 December 2011

 

Pretreatment with A Small-Molecule Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor, UTL-5g, Reduced Radiation-Induced Acute Liver Toxicity in Mice

 

Jiajiu Shaw1*, Jie Zhang2, Ming Zhang 2, Frederick Valeriote3, Ben Chen4

121st Century Therapeutics, Inc., Ferndale, MI 48220, USA

2Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA

3Department of Internal Medicine, Henry Ford Health System, Detroit, MI 48202, USA

4Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA

*Corresponding author:

J. Shaw, Ph.D.

21st Century Therapeutics, Inc..

1366 Hilton Rd., Ferndale

Michigan 48220, USA

Telephone: 734-330-6052

E-mail: jshaw@21-cti.com

 

Abstract

       Radiation-induced liver toxicity is a major limitation to the use of radiation in the treatment of intrahepatic cancers. The purpose of this study was to evaluate the potential radioprotective effect of a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor, UTL-5g, against radiation-induced acute liver injury. Mice were pre-treated by i.p. injection with UTL-5g and control vehicle one hr prior to liver irradiation at 15 Gy. Blood and liver were collected 2 hr after irradiation and analyzed for levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities in serum and TNF-α in liver tissue extracts. Both AST and ALT in serum and TNF-α in liver induced by irradiation were significantly reduced by UTL-5g in a drug dose-dependent manner. The reductions of AST, ALT and TNF-α appeared to correlate with the reduction of liver apoptosis detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. A radiation dose escalation study (5, 15 and 25 Gy) showed that UTL-5g at 60 mg/kg was effective as a radioprotective agent at 5 and 15 Gy; the protection was only modest at 25 Gy. In summary, our results suggest that the TNF-α inhibitor, UTL-5g, is potentially radioprotective against acute phase of radiation-induced liver injury.

 

Keywords: liver, radiation, radioprotective, TNF-α, UTL-5g.

Download the full article (PDF)

 


 

Publisher   |   Missions and Scope   |  Editorial Board   |  Instructions for Authors   |  Contact Us

 

© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved.